BREAKTHROUGHS IN FIGHTING AGE RELATED DISEASE

Symbol CURX
Price 0.0096
Change 0.00%
Volume 6,695
 
curx
 
Quotes delayed at least 20 minutes.
Press Releases
Release Date Title (Click to read)
Nov 7, 2011 Curaxis Pharmaceutical Corporation Management to Meet With Shareholders
Aug 17, 2011 Curaxis Pharmaceutical Corporation Management Working Through Transition Phase and Evaluating Alternatives
Jun 27, 2011 Curaxis Pharmaceutical Corporation Announces Key Changes to Its Board of Directors and Management Team in Progression Toward Clinical Trials
May 10, 2011 Curaxis Pharmaceutical Corporation Chief Executive Officer Comments on Recent NIH Research
May 5, 2011 Curaxis' Memryte Named One of the Top 100 Drugs in Development Today by R&D Directions
Mar 24, 2011 Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Prana Research
Mar 10, 2011 Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent New York Times Article "Drug Firms Face Billions in Losses in '11 as Patents End"
Feb 14, 2011 Curaxis Pharmaceutical Corp. to Meet With Ticino Business Development Office in Lugano, Switzerland
Feb 9, 2011 Curaxis Pharmaceutical Corp. Announces New Listing on the Frankfurt Stock Exchange
Feb 7, 2011 Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Alzheimer's Association Report
Feb 3, 2011 Curaxis Pharmaceutical Management on Roadshow in Europe to Access Capital & Pursue Strategic Partners
Jan 10, 2011 Curaxis Pharmaceutical Corp Confirms Exploration of Frankfurt Exchange Listing
Oct 13, 2010 Curaxis Pharmaceutical Corp CEO Patrick S. Smith Comments on Recent Bioworld Article on Alzheimer's Research
Sep 30, 2010 Curaxis Pharmaceutical Corp CEO Patrick S. Smith Comments on World Alzheimer's Report
Sep 27, 2010 Southridge Partners II Enters Into an Equity Purchase Agreement with Curaxis Pharmaceutical for Clinical Alzheimer's Disease Trials
Sep 22, 2010 Curaxis Pharmaceutical Enters Into an Equity Line Agreement With Southridge Partners, II for Clinical Alzheimer's Disease Trials
Sep 21, 2010 Curaxis Pharmaceutical Corp CEO Patrick S. Smith Comments on Recent Alzheimer's Disease Research
Sep 8, 2010 Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's Treatment
Sep 7, 2010 Curaxis Pharmaceutical Corp. Announces Change of Trading Symbol